MUC1 and head and neck squamous cell carcinoma: It also demonstrated immunological evidence for positive immunomodulation and reversion of immune exclusion, suggesting an active role of tadalafil and an adjuvant to the anti-MUC1 vaccine in advanced HNSCC.